(Q54690022)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15589586%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

HPV16-specific cytotoxic T lymphocyte responses are detected in all HPV16-positive cervical cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15589586%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

main subject

cytotoxicity

0 references

cervix uterine cancer

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15589586%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Victor Valdespino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15589586%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Clara Gorodezky

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15589586%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Vianney Ortiz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15589586%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Andreas M Kaufmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15589586%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Edgar Roman-Basaure

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15589586%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Alejandra Vazquez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15589586%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

English

0 references

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15589586%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15589586%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15589586%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15589586%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

92-102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15589586%20AND%20SRC:MED&resulttype=core&format=json

Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Management of cervical neoplasia in human immunodeficiency virus-infected women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

7 January 2021

A new look at T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Generation of tumor-specific cytotoxic T lymphocytes by stimulation with HPV type 16 E7 peptide-pulsed dendritic cells: an approach to immunotherapy of cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Induction of Cytotoxic T Lymphocytes With Dendritic Cells Transfected With Human Papillomavirus E6 and E7 RNA: Implications for Cervical Cancer Immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Mature dendritic cells prime functionally superior melan-A-specific CD8+ lymphocytes as compared with nonprofessional APC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Complete nucleotide sequence of the nucleoprotein gene from the human influenza strain A/PR/8/34 (HON1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Cell-mediated immune response to human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

7 January 2021

APCs size up antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Potential strategies utilised by papillomavirus to evade host immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Multiple mechanisms underlie HLA dysregulation in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052

Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.08.052